Loading chart...



The current price of DHAI is 0 USD — it has increased 0
DIH Holding US, Inc. is a global provider of advanced robotic devices used in physical rehabilitation. Its rehabilitation hospitals and outpatient clinics offering solutions include ArmeoPower, ArmeoSpring, ArmeoSpring Pro, ArmeoSenso, Erigo, Lokomat, SafeGait 360 by Gorbel, RYSEN, Andago, C-Mill, and HocoNet. Its Research & Academia offering solutions include GRAIL, CAREN Extended, CAREN High-End, M-Gait, and D-Flow. The ArmeoSpring Pro is a cutting-edge medical device designed to bring upper limb rehabilitation to the next level. Its new arm weight support, powered by TrueG technology, allows patients to receive continuous arm weight support from shoulder extension to shoulder flexion. ArmeoPower guides the initial phases of arm and hand function recovery. ArmeoSpring supports the recovery of arm and hand functions. ArmeoSenso is a sensor-based solution for arm function recovery. HocoNet is a software platform connecting product portfolio across the entire continuum of care.
Wall Street analysts forecast DHAI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for DHAI is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
DIH Holding US Inc revenue for the last quarter amounts to 12.65M USD, decreased -34.66
DIH Holding US Inc. EPS for the last quarter amounts to -2.78 USD, decreased -19.42
DIH Holding US Inc (DHAI) has 178 emplpoyees as of April 01 2026.
Today DHAI has the market capitalization of 0.00 USD.